273 related articles for article (PubMed ID: 26825839)
1. Predictors of Survival in Patients With FIGO Stage IVB Cervical Cancer.
Sasano T; Mabuchi S; Kuroda H; Takahashi R; Kozasa K; Isohashi F; Yoshioka Y; Ogawa K; Kimura T
Int J Gynecol Cancer; 2016 Mar; 26(3):528-33. PubMed ID: 26825839
[TBL] [Abstract][Full Text] [Related]
2. Outcome of international Federation of gynecology and obstetrics stage IIb cervical cancer from 2003 to 2012: an evaluation of treatments and prognosis: a retrospective study.
Guo L; Liu X; Wang L; Sun H; Huang K; Li X; Tang F; Li S; Yuan X; Wang C
Int J Gynecol Cancer; 2015 Jun; 25(5):910-8. PubMed ID: 25867278
[TBL] [Abstract][Full Text] [Related]
3. [Analysis of prognostic factors and therapeutic patterns of recurrent stage Ⅰb-Ⅱa cervical squamous carcinoma treated with radical hysterectomy].
Ou ZJ; Zhao D; An JS; Sun CY; Huang MN; Li B; Wu LY
Zhonghua Fu Chan Ke Za Zhi; 2019 Jun; 54(6):399-405. PubMed ID: 31262124
[No Abstract] [Full Text] [Related]
4. Outcomes and toxicities for the treatment of stage IVB cervical cancer.
Hwang JH; Lim MC; Seo SS; Kang S; Park SY; Kim JY
Arch Gynecol Obstet; 2012 Jun; 285(6):1685-93. PubMed ID: 22173823
[TBL] [Abstract][Full Text] [Related]
5. Lack of any impact of histopathology type on prognosis in patients with early-stage adenocarcinoma and squamous cell carcinoma of the uterine cervix.
Teke F; Yoney A; Teke M; Inal A; Urakci Z; Eren B; Zincircioglu SB; Buyukpolat MY; Ozer A; Isikdogan A; Unsal M
Asian Pac J Cancer Prev; 2014; 15(6):2815-9. PubMed ID: 24761906
[TBL] [Abstract][Full Text] [Related]
6. Contributing factors for bone metastasis in uterine cervical cancer.
Yoon A; Choi CH; Kim HJ; Park JY; Lee YY; Kim TJ; Lee JW; Bae DS; Kim BG
Int J Gynecol Cancer; 2013 Sep; 23(7):1311-7. PubMed ID: 23839246
[TBL] [Abstract][Full Text] [Related]
7. Impact of the addition of concurrent chemotherapy to pelvic radiotherapy in surgically treated stage IB1-IIB cervical cancer patients with intermediate-risk or high-risk factors: a 13-year experience.
Okazawa M; Mabuchi S; Isohashi F; Suzuki O; Yoshioka Y; Sasano T; Ohta Y; Kamiura S; Ogawa K; Kimura T
Int J Gynecol Cancer; 2013 Mar; 23(3):567-75. PubMed ID: 23385284
[TBL] [Abstract][Full Text] [Related]
8. Robotic Surgery in Patients With Locally Advanced Cervical Cancer After Neoadjuvant Chemotherapy: Survival Outcomes.
Siesto G; Romano F; Accardi A; Bulletti C; Iedà NP; Vitobello D
Int J Gynecol Cancer; 2016 Mar; 26(3):521-7. PubMed ID: 26825842
[TBL] [Abstract][Full Text] [Related]
9. Extended field radiotherapy with or without chemotherapy in patients with cervical cancer and positive para-aortic lymph nodes: a single institution retrospective review.
Ng BH; Rozita A; Adlinda A; Lee WC; Wan Zamaniah W
Asian Pac J Cancer Prev; 2015; 16(9):3827-33. PubMed ID: 25987044
[TBL] [Abstract][Full Text] [Related]
10. Elevated white blood cell count at the time of recurrence diagnosis is an indicator of short survival in patients with recurrent cervical cancer.
Mabuchi S; Matsumoto Y; Hamasaki T; Kawano M; Hisamatsu T; Mutch DG; Kimura T
Int J Gynecol Cancer; 2012 Nov; 22(9):1545-51. PubMed ID: 23051956
[TBL] [Abstract][Full Text] [Related]
11. Prediction of progression-free survival and response to paclitaxel plus carboplatin in patients with recurrent or advanced cervical cancer.
Hisamatsu T; Mabuchi S; Yoshino K; Fujita M; Enomoto T; Hamasaki T; Kimura T
Int J Gynecol Cancer; 2012 May; 22(4):623-9. PubMed ID: 22343974
[TBL] [Abstract][Full Text] [Related]
12. Pretreatment Mean Apparent Diffusion Coefficient Is Significantly Correlated With Event-Free Survival in Patients With International Federation of Gynecology and Obstetrics Stage Ib to IIIb Cervical Cancer.
Himoto Y; Fujimoto K; Kido A; Baba T; Tanaka S; Morisawa N; Koyasu S; Konishi I; Togashi K
Int J Gynecol Cancer; 2015 Jul; 25(6):1079-85. PubMed ID: 25853385
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of pretreatment 18F-fluorodeoxyglucose uptake in patients with cervical cancer treated with definitive chemoradiotherapy.
Onal C; Reyhan M; Parlak C; Guler OC; Oymak E
Int J Gynecol Cancer; 2013 Jul; 23(6):1104-10. PubMed ID: 23792605
[TBL] [Abstract][Full Text] [Related]
14. Preoperative prognostic factors and effects of adjuvant therapy on outcomes of early stage cervical cancer in Iran.
Behtash N; Karimi Zarchi M; Deldar M
Asian Pac J Cancer Prev; 2009; 10(4):613-8. PubMed ID: 19827880
[TBL] [Abstract][Full Text] [Related]
15. The Glasgow Prognostic Score Determined During Concurrent Chemoradiotherapy Is an Independent Predictor of Survival for Cervical Cancer.
Nishida T; Nakamura K; Haraga J; Ogawa C; Kusumoto T; Seki N; Masuyama H; Katayama N; Kanazawa S; Hiramatsu Y
Int J Gynecol Cancer; 2015 Sep; 25(7):1306-14. PubMed ID: 26067860
[TBL] [Abstract][Full Text] [Related]
16. Hydronephrosis as a prognostic indicator of survival in advanced cervix cancer.
Pradhan TS; Duan H; Katsoulakis E; Salame G; Lee YC; Abulafia O
Int J Gynecol Cancer; 2011 Aug; 21(6):1091-6. PubMed ID: 21738045
[TBL] [Abstract][Full Text] [Related]
17. Analysis of prognostic variables, development of predictive models, and stratification of risk groups in surgically treated FIGO early-stage (IA-IIA) carcinoma cervix.
Singh P; Tripcony L; Nicklin J
Int J Gynecol Cancer; 2012 Jan; 22(1):115-22. PubMed ID: 21997176
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of radical doses of pelvic radiotherapy for primary tumor treatment in patients with newly diagnosed organ metastatic cervical cancer.
Yin Z; Lou H; Tang H; Ni J; Zhou Q; Chen M
Radiat Oncol; 2019 May; 14(1):82. PubMed ID: 31109371
[TBL] [Abstract][Full Text] [Related]
19. Pattern of Care, Health Care Disparities, and Their Impact on Survival Outcomes in Stage IVB Cervical Cancer: A Nationwide Retrospective Cohort Study.
Jalloul RJ; Sharma S; Tung CS; O'Donnell B; Ludwig M
Int J Gynecol Cancer; 2018 Jun; 28(5):1003-1012. PubMed ID: 29757872
[TBL] [Abstract][Full Text] [Related]
20. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.
Kasuya G; Ogawa K; Iraha S; Nagai Y; Hirakawa M; Toita T; Kakinohana Y; Kudaka W; Inamine M; Ariga T; Aoki Y; Murayama S
Anticancer Res; 2013 May; 33(5):2199-204. PubMed ID: 23645776
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]